MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.
(2011) In Journal of Proteomics 75(1). p.211-220- Abstract
- As a proof-of-principle study, a multiple reaction monitoring (MRM) assay was developed for quantitation of proteotypic peptides, representing seven plasma proteins associated with inflammation (complement components and C-reactive protein). The assay development and the sample analysis were performed on a linear ion trap mass spectrometer. We were able to quantify 5 of the 7 target proteins in depleted plasma digests with reasonable reproducibility over a 2 orders of magnitude linear range (RSD < 25%). The assay panel was utilized for the analysis of a small multiple sclerosis sample cohort with 10 diseased and 8 control patients.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2007751
- author
- Rezeli, Melinda
LU
; Végvári, Ákos LU ; Ottervald, Jan ; Olsson, Tomas LU ; Laurell, Thomas LU and Marko-Varga, György LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- linear ion trap, multiple sclerosis, selective reaction monitoring
- in
- Journal of Proteomics
- volume
- 75
- issue
- 1
- pages
- 211 - 220
- publisher
- Elsevier
- external identifiers
-
- wos:000298710400021
- pmid:21703369
- scopus:82955196277
- pmid:21703369
- ISSN
- 1874-3919
- DOI
- 10.1016/j.jprot.2011.05.042
- language
- English
- LU publication?
- yes
- id
- a263c94a-0257-4f07-9959-2cb4c36b2486 (old id 2007751)
- date added to LUP
- 2016-04-01 10:26:34
- date last changed
- 2025-04-04 13:55:22
@article{a263c94a-0257-4f07-9959-2cb4c36b2486, abstract = {{As a proof-of-principle study, a multiple reaction monitoring (MRM) assay was developed for quantitation of proteotypic peptides, representing seven plasma proteins associated with inflammation (complement components and C-reactive protein). The assay development and the sample analysis were performed on a linear ion trap mass spectrometer. We were able to quantify 5 of the 7 target proteins in depleted plasma digests with reasonable reproducibility over a 2 orders of magnitude linear range (RSD < 25%). The assay panel was utilized for the analysis of a small multiple sclerosis sample cohort with 10 diseased and 8 control patients.}}, author = {{Rezeli, Melinda and Végvári, Ákos and Ottervald, Jan and Olsson, Tomas and Laurell, Thomas and Marko-Varga, György}}, issn = {{1874-3919}}, keywords = {{linear ion trap; multiple sclerosis; selective reaction monitoring}}, language = {{eng}}, number = {{1}}, pages = {{211--220}}, publisher = {{Elsevier}}, series = {{Journal of Proteomics}}, title = {{MRM assay for quantitation of complement components in human blood plasma - a feasibility study on multiple sclerosis.}}, url = {{https://lup.lub.lu.se/search/files/1848029/2028880.pdf}}, doi = {{10.1016/j.jprot.2011.05.042}}, volume = {{75}}, year = {{2011}}, }